Accepted at 2:34 p.m. Oct, 02, 2023 by dollajas
Author: emgleason
Related Note: 1496872303888
Rationale for change

I think this should be more specific--most of the sxs of Lesch-Nyhan aren't treatable (self-mutilation, cognitive delay, etc.) so XO inhibitors only address the hyperuricemia but won't fix the other issues

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#B&B::04_Biochem::01_Molecular::02_Purine_Metabolism::Extra #AK_Step1_v12::#Pixorize::01_Biochemistry::03_Metabolic_Disorders::17_Lesch-Nyhan_Syndrome #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs::*Basics::Uric_Acid_Metabolism #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Nephrology_&_Urology::Gout_Drugs #AK_Step1_v12::#SketchyBiochem::03_Molecular_Biology::01_DNA::07_Purine_Salvage_Deficiencies_Adenosine_Deaminase_Deficiency_Lesch-Nyhan_Syndrome #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs::01_Chronic_gout_drugs_(preventive)::*Allopurinol_Febuxostat #AK_Step1_v12::#OME::PreClinical::Biochemistry #AK_Step1_v12::#UWorld::Step::6611 #AK_Step1_v12::#Bootcamp::Genetics::01_DNA_Structure::03_Clinical_Applications_of_the_Purine_Pathway #AK_Step1_v12::#AMBOSS::mSaVZ4 #AK_Step2_v12::#B&B::09_MSK::01_General::03_Gout::Extra #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::08_Acute_and_Chronic_Gout_Treatment #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-Inflammatory::02_Gout_Drugs::zanki_extra #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-Inflammatory::02_Gout_Drugs #AK_Other::!AK_UpdateTags::AnKing_Image::Aiman::Gout_Drugs #AK_Step1_v12::#AMBOSS::OSaI-P #AK_Step1_v12::#AMBOSS #AK_Step1_v12::^Other::^EXPN